Radiation Therapy News and Research RSS Feed - Radiation Therapy News and Research

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
ECOG-ACRIN Cancer Research Group opens clinical trial for women with newly diagnosed DCIS

ECOG-ACRIN Cancer Research Group opens clinical trial for women with newly diagnosed DCIS

In direct response to recommendations made by a National Institutes of Health scientific consensus panel, the ECOG-ACRIN Cancer Research Group announced today the opening of E4112, a clinical trial for women with newly diagnosed ductal carcinoma in situ (DCIS) of the breast who, together with their doctors, will use the results of a magnetic resonance imaging (MRI) exam to determine whether to undergo a lumpectomy or a mastectomy. [More]
Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain. [More]
Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

A new molecule has been found that protects the heart from toxic breast cancer drugs and also kills the cancerous tumour. The research from Italy addresses the burgeoning problem of heart disease in cancer survivors and is announced by the European Society of Cardiology today on World Cancer Day. [More]
New study identifies three genes that enable glioblastoma to recur, progress after radiation therapy

New study identifies three genes that enable glioblastoma to recur, progress after radiation therapy

A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy. [More]
Clusters of gene-blocking microRNAs can limit spread of cancer

Clusters of gene-blocking microRNAs can limit spread of cancer

Cancers that have spread throughout the body, a process known as metastasis, are difficult, often impossible, to control. They are the leading cause of cancer-related deaths. [More]
NQMBC recognizes Cancer Treatment Centers of America for providing quality breast cancer care

NQMBC recognizes Cancer Treatment Centers of America for providing quality breast cancer care

Cancer Treatment Centers of America at Midwestern Regional Medical Center has been recognized by the National Quality Measures for Breast Centers Program as being among the top centers in the country for providing quality breast cancer care. [More]
Mathematical models of cancer behavior offer new insights on tumor growth

Mathematical models of cancer behavior offer new insights on tumor growth

Hassan Fathallah-Shaykh, M.D., Ph.D., believes that math can transform medicine, and he has the numbers to prove it. [More]
Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Improving access to care is an important focus at Meridian Health, and a new partnership with Jersey Coast Vascular Institute is making high quality vascular services more readily available for local residents. [More]
CHLA researchers develop new protein-based therapy against drug-resistant leukemia cells

CHLA researchers develop new protein-based therapy against drug-resistant leukemia cells

Resistance of leukemia cells to contemporary chemotherapy is one of the most formidable obstacles to treating acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Now researchers at Children's Hospital Los Angeles have designed and developed a new protein-based therapy they believe will prove highly effective against drug-resistant leukemia cells. [More]
Altered AHNAK gene may open door to improved treatment for keloid scars

Altered AHNAK gene may open door to improved treatment for keloid scars

Researchers at Henry Ford Hospital in Detroit have identified a gene that may offer a better understanding of how keloid scars develop and potentially open the door to improved treatment for the often painful, itchy and tender scars. [More]
Elekta updates latest R&D work with special focus on high field MRI-guided radiation therapy

Elekta updates latest R&D work with special focus on high field MRI-guided radiation therapy

Elekta updated the market this morning on its latest research and development initiatives, with special focus on Atlantic, the first generation high field MRI-guided radiation therapy system. The company unveiled plans to introduce this game-changing technology in 2017 and deliver the first systems in 2018. [More]
Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS

Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS

As part of consolidating the cancer care of four Western Australian public services into a single, multi-disciplinary facility, the clinics will transition from their existing oncology information systems (OIS) to Elekta's MOSAIQ OIS. [More]
BMG Pharma S.R.L Grants The Exclusive Distribution Rights For Gelx® Oral Gel And Gelx® Spray For The Treatment Of Oral Mucositis In Cancer Patients To FERRER INTERNACIONAL S.A.

BMG Pharma S.R.L Grants The Exclusive Distribution Rights For Gelx® Oral Gel And Gelx® Spray For The Treatment Of Oral Mucositis In Cancer Patients To FERRER INTERNACIONAL S.A.

BMG Pharma S.r.l. today is pleased to announce that it has signed an exclusive distribution agreement with FERRER INTERNACIONAL S.A., granting them the rights to promote, sell and market its own product GelX for the Middle East, Eastern Europe, Russia and North Africa. [More]
ArborMetrix's RegistryMetrix analytics platform selected for UNC's urology department

ArborMetrix's RegistryMetrix analytics platform selected for UNC's urology department

ArborMetrix, Inc., a leading provider of cloud-based healthcare analytics solutions, today announced that the Urology Department of the University of North Carolina School of Medicine is using its cloud-based RegistryMetrix analytics platform. [More]
Palmetto GBA issues positive coverage policy for GenomeDx's Decipher prostate cancer test

Palmetto GBA issues positive coverage policy for GenomeDx's Decipher prostate cancer test

GenomeDx Biosciences today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has issued a positive coverage policy through the MolDX Program for the company's Decipher prostate cancer classifier. [More]
Two medical organizations recommend use of HPV test for cervical cancer screening

Two medical organizations recommend use of HPV test for cervical cancer screening

Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing with cytology and HPV testing. [More]

Survey shows radiation oncologists desire for more formal guidance to improve peer review process

Peer review is a common practice in medicine to support the complementary, multidisciplinary team approach in healthcare. A 2013 survey of radiation oncologists indicates that they would like more formal recommendations and guidance in order to improve the peer review process, according to a study published in the January-February 2015 issue of Practical Radiation Oncology, the clinical practice journal of the American Society for Radiation Oncology. [More]
Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Carl Zeiss Meditec AG and Oraya Therapeutics, Inc. jointly announced today that the companies have entered into a collaboration agreement under which Carl Zeiss Meditec will provide funding to Oraya over a period of up to two years for the implementation of Oraya’s growth strategy, and in turn receive rights in the company reaching up to a majority stake after two years. [More]
Many breast cancer patients undergoing lumpectomy surgery benefit from new intra-operative technology

Many breast cancer patients undergoing lumpectomy surgery benefit from new intra-operative technology

Many patients undergoing lumpectomy surgery at NYU Langone Medical Center for the removal of an early detected breast tumor - the surgical option of choice for this diagnosis -- are benefitting from new intra-operative technology that detects microscopic amounts of cancer cells on removed tumor tissue not visible during or following surgical intervention. [More]
Holding breath during radiation therapy can reduce radiation exposure to the heart

Holding breath during radiation therapy can reduce radiation exposure to the heart

Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment because it can be difficult to ensure that a sufficient dose of radiation is delivered to the left breast while adequately shielding the heart from exposure. [More]